title: Hematopoietic growth factors in cancer chemotherapy.
authors.affiliation: Amgen Inc., Thousand Oaks, CA 91320-1789, USA.
authors.forename: G
authors.initials: G
authors.lastname: Morstyn
authors.forename: M
authors.initials: M
authors.lastname: Foote
authors.forename: G J
authors.initials: GJ
authors.lastname: Lieschke
mesh_terms: D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D016179:Granulocyte Colony-Stimulating Factor / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor